Asia Tech Times — Technology, science and culture across Asia

Technology, science and culture across Asia

Business Tech

The week in Asian tech: AI capex, China biotech and crypto's brokerage turn

This week's roundup: HCLTech's bookings, AI server forecasts, Bybit's equities push, Chinese biotech and clean energy.

The week's biggest stories were not just product launches: Asia's technology economy showed up in earnings, infrastructure forecasts and clinical trials. HCLTech gave the region's IT services sector a hard number to argue with, while the AI server market's projected trillion-dollar scale explained why so much capital is still flowing into data centres. Elsewhere, the line between crypto and traditional brokerage blurred further, and Chinese biotech and hydro both notched milestones.

HCLTech posts $3.3bn in quarterly bookings as EBIT margin reaches 18.2%

Quarterly bookings of $3.3bn and an 18.2% EBIT margin, with revised full-year guidance, make this the week's clearest read on Indian IT demand. The revenue growth was modest, so the numbers matter less for the headline than for what they say about AI contracts replacing slower legacy work.

Data center server market projected to reach USD 1.31 trillion by 2035

DC Market Insights projects the data-center server market will reach $1.31 trillion by 2035, with AI servers averaging about $178,500 per unit in 2025. The forecast is a useful reminder that Asia's chip, rack and cooling supply chains are being pulled by an AI capex cycle that still has no obvious peak.

Bybit adds trading in more than 1,000 U.S. stocks and ETFs

Bybit will let eligible users trade more than 1,000 U.S. stocks and ETFs using USDC, with orders routed through Alpaca. It is a significant step in crypto exchanges becoming full brokerages, and it will be worth watching how Asian regulators treat the custody and settlement boundaries.

Akeso doses first patient in Phase III colon cancer study of cadonilimab

Akeso dosed the first patient in a Phase III trial of cadonilimab as perioperative monotherapy in resectable MSI-H/dMMR colon cancer. For Asian biotech, this is the kind of global, practice-changing study that matters more than another early-stage licensing deal.

First Two Units at Dashixia Dam Connect to Grid in Xinjiang

The first two units at the 247-meter Dashixia dam in Xinjiang connected to the grid on Sept. 29. It is a major addition to China's hydro fleet and a test of how Beijing balances clean-energy expansion with water and regional politics in the Tianshan.

HONOR announces X9e Pro with 11,000mAh battery and 3-metre drop resistance

HONOR's X9e Pro pairs an 11,000mAh battery with three-metre drop resistance and AI features. The phone is a consumer launch, but it captures a broader shift among Chinese handset makers toward battery life and durability as differentiators.

RingConn smart ring receives FDA 510(k) clearance for blood oxygen measurement

Shenzhen Ninenovo's RingConn smart ring received FDA 510(k) clearance for non-invasive blood oxygen measurement. A Chinese wearable clearing U.S. health-review for SpO2 is a meaningful regulatory validation for the category, where accuracy claims face growing scrutiny.

The through-line is that Asia's tech story this week was less about novelty than scale: bigger contracts, bigger forecasts and bigger claims being tested.

Ask about this ChatGPT Claude Perplexity